NuvaRing®

 

A hormonal birth control device, NuvaRing® is inserted into the vagina for three weeks at a time.  While in place, the ring prevents pregnancy by releasing artificial forms of estrogen and progestin.  The makers of NuvaRing® claim that the product is safer and more convenient than birth control pills. However, NuvaRing® poses serious health risks, including:

 

• Blood clots

• Stroke

• Myocardial infarction (heart attack)

• High blood pressure

• Heart disease

• Gall bladder disease

 

If you currently use NuvaRing®, please see your doctor to discuss these potentially life-threatening complications.

If you have been injured after using NuvaRing®, please contact our office for a free consultation discussing your legal options.

2) NuvaRing®

 

NuvaRing®

This firm currently representing women who have suffered injuries associated with their use of NuvaRing®. The following symptoms are caused by NuvaRing®.

• Stroke

• Pulmonary Embolism

• Deep Vein thrombosis (DVT)

NuvaRing® is a contraceptive drug that is absorbed by the female body from a flexible ring that is inserted in the vagina for weeks at a time.  The product has been approved by the FDA and is manufactured by Organon USA, Inc., which is currently owned by Schering-Plough Corporation.  NuvaRing® is believed to be linked to serious venous thromboembolic events including deep vein thrombosis, blood clots pulmonary embolism, stroke and heart attack leading to death.

NuvaRing® is flexible vaginal ring which contains a combination of the hormones estrogen and progestin, or ethinyl estradiol and etonogestrel, respectively.  Etonogestrel is the active metabolite of desogestrel, a synthetic form of the naturally occurring female sex hormone progesterone.  Etonogestrel is a progestin that has been cited in articles as a progestin more likely to produce thrombosis.  These findings, as well as those from other studies, were based upon analysis of the effect of contraceptives containing desogestrel that are absorbed by the female body in oral form.  Contraceptives containing desogestrel that are absorbed by the female body in oral form.  Contraceptives containing desogestrel are otherwise known as third generation contraceptives.  In February 2007, the consumer watchdog group public Citizen petitioned the FDA to ban a number of third generation contraceptives.

The NuvaRing® contraceptive ring is designed to prevent pregnancy by releasing a combination of estrogen and progestin through the walls of the vagina into the bloodstream over the course of three weeks during a 28-day cycle.

The current label and package insert for NuvaRing® does not sufficiently report the potential serious health effects associated with the use of NuvaRing®.  To date, there is no comprehensive study o the long-term health effects of vaginal delivery of the drug combination in NuvaRing®.

Please call or write for a free consultation or more information

 

3) NuvaRing®

 

This firm currently represents women who have suffered injuries associated with their use of NuvaRing.  NuvaRing is believed to be linked to serious venous thromboembolic events including deep vein thrombosis, blood clots, pulmonary embolism, stroke, heart attack and even death.  The current label and package insert for NuvaRing fails to adequately warn women of these potentially serious health effects.

 

NuvaRing is a contraceptive drug designed to prevent pregnancy.  The flexible ring is inserted into the vagina and works by releasing estrogen and progestin -- through the walls of the vagina -- into the bloodstream over the course of three weeks during a woman’s 28-day cycle.  The product is FDA approved and is manufactured by Organon USA, Inc. 

 

NuvaRing contains a combination of the hormones estrogen and progestin, or ethinyl estradiol and etonogestrel, respectively.  Etonogestrel is the active metabolite of desogestrel, a synthetic form of the naturally occurring female sex hormone progesterone.  Etonogestrel is a progestin that has been cited in articles as a progestin more likely to produce thrombosis.  These findings, as well as those from other studies, were based upon an analysis of the effect of contraceptives containing desogestrel that are absorbed by the female body in oral form.  Contraceptives containing desogestrel are otherwise known as third generation contraceptives.  In February 2007, the consumer watchdog group Public Citizen petitioned the FDA to ban a number of third generation contraceptives. 

 

If you have suffered as a result of using NuvaRing, please call or write to our offices for a free consultation or more information about your legal rights.